Hope for Meth Addicts
Also in DrugReporter
When It’s Crunch Time at College, Students Turn to Adderall
Erik Hayden
In Historic Shift, the American Medical Association Sees Value in Marijuana
Phillip S. Smith
The Relentless War on Drug Users Is Escalating Violence in the US: It's Time for Harm Reduction
Don Hazen
Drug Policy Alliance Conference Comes at a Crucial Moment for Drug Reform
Anthony Papa
Why Are We Locking Up Traumatized Veterans for Their Addictions Instead of Offering Them Treatment?
Penny Coleman
Lies About Marijuana Drive People to a Much More Harmful Drug -- Booze
Steve Fox
In a moving and brutally honest account of his son's methamphetamine addiction in The New York Times Magazine, David Sheff noted that the addiction treatment industry "must be the most chaotic and flailing field of health care in America." When he asked about treatment success rates for meth addiction, he writes, "I was quoted success rates in a range from 20 to 85 percent. An admitting nurse at a North California hospital insisted: 'The true number for meth addicts is in the single digits. Anyone who promises more is lying.'"
In fact, actual research studies – and Sheff's son's own story – suggest a brighter picture than the nurse claims. Methamphetamine addicts have relapse rates no worse – and no better – than for those of any other drug. If you compare the course of various addictions, alcoholism and opioid addictions tend to run longer than meth addiction.
This is because alcohol and opioids like heroin tend to put users to sleep and calm them – but stimulants like cocaine and methamphetamine keep users awake for days on end, causing anxiety and paranoia. There is only so much sleep loss one can take: After a few years of such a lifestyle, stimulant addicts tend to quit, switch to more calming drugs, or, in a minority of cases, die. If you determine "addictiveness" by how long one's life is dominated by a drug, then, cocaine and amphetamine are less addictive.
Of course, the admitting nurse is correct to say that rehab facilities over-promise when they claim 85 percent success rates – but single digit success is not correct either. Research has consistently shown one-year abstinence rates from all addictions following treatment at about 40-60 percent, with an additional 15-30 percent having some relapses but not returning to chronic daily use. This is actually slightly better than for other chronic illnesses which require lifestyle changes for successful outcomes, like diabetes and hypertension. The prognosis is more positive for people of high socioeconomic status, with college educations and with strong family support.
The problem with addiction treatment now is not that it doesn't work, but that the best treatment is hard to find and that outdated methods still dominate the field. Parents and reporters like Sheff need to demand that this "chaotic and flailing" field adopt evidence-based methods to improve outcomes – not hype "the worst drug ever" over and over as different drugs fall in and out of favor.
Maia Szalavitz is a senior fellow at the media watchdog group STATS.
Liked this story? Get top stories in your inbox each week from DrugReporter! Sign up now »
| More News and Analysis: | ||
|
15 Signs American Society Is Coming Apart at the Seams Corporate Accountability and WorkPlace: Are we nearing a tipping point as rapacious elites push a heavily armed populace too far? By David DeGraw, Amped Status. November 21, 2009. |
Naomi Klein: 'No Logo' Revisited In the new introduction to the re-release of her classic book, 'No Logo,' Klein explores how ad culture has thrived and adapted in the past decade. By Naomi Klein, Picador Press. November 21, 2009. |
Is Right-Wing Media Hustler Trying to "Blackmail" Obama's Attorney General over ACORN Videos? Media and Technology: Andew Breitbart appears to be threatening to release more ACORN smear videos to avoid a serious DOJ investigation. By David Edwards, Muriel Kane, Raw Story. November 21, 2009. |
Support AlterNet
Do you value the information you're getting from AlterNet? Please show your support with a tax-deductible donation.
Feedback
Tell us how we're doing.